HB 6913 Summary

• Substance abuse treatment facilities must retain records of patients, contact them at least once every four months for one year after treatment ends, and offer referrals to additional treatment services if needed.

• Each institution of higher education must develop and implement a policy on opioid antagonist availability by January 1, 2024, designating staff to oversee purchase and storage, identifying accessible locations, and requiring emergency medical services notification when antagonists are used.

• Department of Mental Health and Addiction Services must establish a pilot program by January 1, 2024 allowing licensed providers to prescribe FDA-approved digital therapeutics for substance use disorder treatment to up to 1,000 patients for at least three months.

• Practitioners transporting controlled substances to patient locations must notify the Department of Consumer Protection, cannot transport within 500 feet of schools or public parks (except private residences), and must report dispensations to the prescription drug monitoring program.

• Multiple state departments must develop plans by January 1, 2024 addressing substance use disorder treatment for parents and caregivers, including access to medication-assisted treatment, child care subsidies, supportive housing, and family-centered services.